Recent Finacing
Recent Raise
ADARx Pharmaceuticals is a San Diego-based clinical-stage biotech developing RNA-targeting oligonucleotides and proprietary PLR™/SPE™ delivery platforms for inhibition, degradation, base editing, and a pipeline including ADX-324 (Phase I).
